US95075A1079
US95075A1079
Werewolf Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | 1.885.000 | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 60.677.000 | 75.479.000 | 19.6% | |
| Operating Income | -60.677.000 | -73.594.000 | 17.6% |
| Pretax Income | -60.822.000 | -70.515.000 | 13.7% |
| Net Income Common Stockholders | -60.822.000 | -70.515.000 | 13.7% |
| -- | -- | -- | |
| -- | -- | -- |